BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19618299)

  • 1. Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease.
    Zhang Y; Hong J; Gu W; Gui M; Chen Y; Zhang Y; Chi Z; Wang W; Li X; Ning G
    Endocrine; 2009 Oct; 36(2):233-8. PubMed ID: 19618299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
    Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
    J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and gallstone disease.
    Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
    World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals.
    DeBoer MD; Filipp SL; Gurka MJ
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):92-98. PubMed ID: 31662283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Metabolic Syndrome Score, Metabolic Syndrome, and Its Individual Components on the Prevalence and Severity of Angiographic Coronary Artery Disease.
    Gui MH; Ling Y; Liu L; Jiang JJ; Li XY; Gao X
    Chin Med J (Engl); 2017 Mar; 130(6):669-677. PubMed ID: 28303849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women.
    Zabetian A; Hadaegh F; Azizi F
    Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):525-31. PubMed ID: 18523915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China.
    Zhou J; Gao Q; Wang J; Zhang M; Ma J; Wang C; Chen H; Peng X; Hao L
    BMJ Open; 2018 Oct; 8(10):e022974. PubMed ID: 30366915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between smoking, components of metabolic syndrome and lipoprotein particle size.
    Slagter SN; van Vliet-Ostaptchouk JV; Vonk JM; Boezen HM; Dullaart RP; Kobold AC; Feskens EJ; van Beek AP; van der Klauw MM; Wolffenbuttel BH
    BMC Med; 2013 Sep; 11():195. PubMed ID: 24228807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patients.
    Mayer O; Bruthans J; Seidlerová J; Karnosová P; Vaněk J; Hronová M; Gelžinský J; Cvíčela M; Wohlfahrt P; Cífková R; Filipovský J
    Eur J Intern Med; 2018 Jan; 47():55-61. PubMed ID: 28755847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study.
    Rachas A; Raffaitin C; Barberger-Gateau P; Helmer C; Ritchie K; Tzourio C; Amouyel P; Ducimetière P; Empana JP
    Heart; 2012 Apr; 98(8):650-5. PubMed ID: 22505463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes.
    Gurka MJ; Guo Y; Filipp SL; DeBoer MD
    Cardiovasc Diabetol; 2018 Jan; 17(1):17. PubMed ID: 29351794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight, the metabolic syndrome, and coronary heart disease in type 2 diabetes: associations among a national French sample of adults with diabetes-the ENTRED study.
    Hillier TA; Fosse S; Balkau B; Simon D; Eschwège E; Fagot-Campagna A
    J Cardiometab Syndr; 2006; 1(5):318-25. PubMed ID: 17679788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
    Lim HS; Lip GY; Beevers DG; Blann AD
    Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men.
    Hadaegh F; Khalili D; Ghasemi A; Tohidi M; Sheikholeslami F; Azizi F
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):401-8. PubMed ID: 19091534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The most appropriate cut-off point of anthropometric indices in predicting the incidence of metabolic syndrome and its components.
    Farhangiyan Z; Latifi SM; Rashidi H; Shahbazian H
    Diabetes Metab Syndr; 2019; 13(4):2739-2745. PubMed ID: 31405702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome in patients with first-ever ischemic stroke: prevalence and association with coronary heart disease.
    Liang Y; Yan Z; Hao Y; Wang Q; Zhang Z; She R; Wang P; Du Y; Lau JT; Dekker J; Bai B; Qiu C
    Sci Rep; 2022 Jul; 12(1):13042. PubMed ID: 35906390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: a matched cohort study.
    Esteghamati A; Hafezi-Nejad N; Sheikhbahaei S; Heidari B; Zandieh A; Ebadi M; Nakhjavani M
    J Clin Lipidol; 2014; 8(3):279-86. PubMed ID: 24793349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between metabolic syndrome and target organ damage in Ghanaian with stage-2 hypertension.
    Bello-Rodriguez BM; Sanchez-Cruz G; Delgado-Bustillo F; Asiama G
    Ghana Med J; 2013 Dec; 47(4):189-96. PubMed ID: 24669025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
    Bianchi C; Penno G; Malloggi L; Barontini R; Corfini M; Giovannitti MG; Di Cianni G; Del Prato S; Miccoli R
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):31-8. PubMed ID: 17420118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.